Yoichi Ajiro
Overview
Explore the profile of Yoichi Ajiro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kishimoto A, Komiyama M, Wada H, Satoh-Asahara N, Yamakage H, Ajiro Y, et al.
J Health Popul Nutr
. 2024 Jun;
43(1):93.
PMID: 38915116
Introduction: Even after the peak of the COVID-19 pandemic, the number of mild cases remains high, requiring continuous control. Curcumin, owing to its anti-inflammatory properties, can suppress vital proliferation and...
2.
Shiga T, Kimura T, Fukushima N, Yoshiyama Y, Iwade K, Mori F, et al.
Clin Ther
. 2022 Oct;
44(11):1494-1505.
PMID: 36244853
Purpose: Several landmark trials have reported that direct oral anticoagulants (DOACs) are more effective in preventing stroke and systemic embolism than vitamin K antagonists. However, nonadherence to DOACs worsens prognosis...
3.
Funamoto M, Sunagawa Y, Katanasaka Y, Kato T, Funada J, Ajiro Y, et al.
Eur Heart J Open
. 2022 Sep;
2(5):oeac057.
PMID: 36172003
Aims: Hypertension is a strong risk factor for heart failure with preserved ejection fraction. Curcumin has p300-specific histone acetyltransferase inhibitory activity, suppresses cardiomyocyte hypertrophy and fibrosis, and significantly reduces myocardial...
4.
Wada H, Shinozaki T, Suzuki M, Sakagami S, Ajiro Y, Funada J, et al.
J Am Heart Assoc
. 2022 Jan;
11(3):e023464.
PMID: 35048713
Background The impact of chronic kidney disease (CKD) on the prognostic utility of cardiovascular biomarkers in high-risk patients remains unclear. Methods and Results We performed a multicenter, prospective cohort study...
5.
Iguchi M, Wada H, Shinozaki T, Suzuki M, Ajiro Y, Matsuda M, et al.
ESC Heart Fail
. 2021 Aug;
8(5):4187-4198.
PMID: 34387398
Aims: Endothelial cell vascular endothelial growth factor receptor 2 (VEGFR-2) plays a pivotal role in angiogenesis, which induces physiological cardiomyocyte hypertrophy via paracrine signalling between endothelial cells and cardiomyocytes. We...
6.
Ajiro Y, Nino H, Ueda T, Bonkohara Y
JTCVS Tech
. 2021 Jul;
1:69-71.
PMID: 34317719
No abstract available.
7.
Shiga T, Kimura T, Fukushima N, Yoshiyama Y, Iwade K, Mori F, et al.
J Arrhythm
. 2021 Jun;
37(3):616-625.
PMID: 34141014
Background: Nonadherence diminishes the efficacy of direct oral anticoagulants (DOACs) in patients with nonvalvular atrial fibrillation (NVAF). This report presents the baseline survey results regarding medication adherence among NVAF patients...
8.
Wada H, Suzuki M, Matsuda M, Ajiro Y, Shinozaki T, Sakagami S, et al.
J Am Heart Assoc
. 2020 Nov;
9(22):e018217.
PMID: 33170061
Background Whether circulating growth differentiation factor 15 (GDF-15) levels differ according to smoking status and whether smoking modifies the relationship between GDF-15 and mortality in patients with coronary artery disease...
9.
Koike T, Mori F, Maeda R, Kobayashi K, Sakai M, Oyabu K, et al.
BMC Cardiovasc Disord
. 2020 Sep;
20(1):413.
PMID: 32917143
Background: Atrial fibrillation and heart failure are common coexisting conditions requiring hospitalisation for heart failure and death. Pulmonary vein isolation is a well-established option for symptomatic atrial fibrillation and for...
10.
Wada H, Suzuki M, Matsuda M, Ajiro Y, Shinozaki T, Sakagami S, et al.
J Am Heart Assoc
. 2020 Apr;
9(9):e015761.
PMID: 32319336
Background VEGF-D (vascular endothelial growth factor D) and VEGF-C are secreted glycoproteins that can induce lymphangiogenesis and angiogenesis. They exhibit structural homology but have differential receptor binding and regulatory mechanisms....